nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Abnormal behaviour—Temozolomide—malignant glioma	0.0466	0.0631	CcSEcCtD
Glycopyrrolate—Injection site reaction—Carmustine—malignant glioma	0.0179	0.0242	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Temozolomide—malignant glioma	0.0142	0.0193	CcSEcCtD
Glycopyrrolate—Nasal congestion—Temozolomide—malignant glioma	0.0138	0.0187	CcSEcCtD
Glycopyrrolate—Affect lability—Temozolomide—malignant glioma	0.0124	0.0168	CcSEcCtD
Glycopyrrolate—Mood swings—Temozolomide—malignant glioma	0.0119	0.0162	CcSEcCtD
Glycopyrrolate—Dehydration—Temozolomide—malignant glioma	0.0117	0.0159	CcSEcCtD
Glycopyrrolate—Dry skin—Temozolomide—malignant glioma	0.0116	0.0156	CcSEcCtD
Glycopyrrolate—Abdominal distension—Temozolomide—malignant glioma	0.011	0.0148	CcSEcCtD
Glycopyrrolate—Dysuria—Temozolomide—malignant glioma	0.0102	0.0138	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Carmustine—malignant glioma	0.0102	0.0138	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0101	0.0137	CcSEcCtD
Glycopyrrolate—Pneumonia—Carmustine—malignant glioma	0.0101	0.0137	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Temozolomide—malignant glioma	0.01	0.0136	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Temozolomide—malignant glioma	0.00983	0.0133	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Carmustine—malignant glioma	0.00977	0.0132	CcSEcCtD
Glycopyrrolate—Pneumonia—Temozolomide—malignant glioma	0.00977	0.0132	CcSEcCtD
Glycopyrrolate—Infestation NOS—Temozolomide—malignant glioma	0.00971	0.0132	CcSEcCtD
Glycopyrrolate—Infestation—Temozolomide—malignant glioma	0.00971	0.0132	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Temozolomide—malignant glioma	0.00944	0.0128	CcSEcCtD
Glycopyrrolate—Sinusitis—Temozolomide—malignant glioma	0.00911	0.0123	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Carmustine—malignant glioma	0.00898	0.0122	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Carmustine—malignant glioma	0.00887	0.012	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Temozolomide—malignant glioma	0.00868	0.0117	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Temozolomide—malignant glioma	0.00861	0.0117	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Temozolomide—malignant glioma	0.00857	0.0116	CcSEcCtD
Glycopyrrolate—Urethral disorder—Temozolomide—malignant glioma	0.00855	0.0116	CcSEcCtD
Glycopyrrolate—Flushing—Carmustine—malignant glioma	0.00838	0.0113	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Temozolomide—malignant glioma	0.00809	0.011	CcSEcCtD
Glycopyrrolate—Flushing—Temozolomide—malignant glioma	0.00809	0.011	CcSEcCtD
Glycopyrrolate—Mental disorder—Carmustine—malignant glioma	0.00791	0.0107	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Temozolomide—malignant glioma	0.00786	0.0106	CcSEcCtD
Glycopyrrolate—Erythema—Carmustine—malignant glioma	0.00786	0.0106	CcSEcCtD
Glycopyrrolate—Malnutrition—Carmustine—malignant glioma	0.00786	0.0106	CcSEcCtD
Glycopyrrolate—Mental disorder—Temozolomide—malignant glioma	0.00764	0.0103	CcSEcCtD
Glycopyrrolate—Erythema—Temozolomide—malignant glioma	0.00759	0.0103	CcSEcCtD
Glycopyrrolate—Malnutrition—Temozolomide—malignant glioma	0.00759	0.0103	CcSEcCtD
Glycopyrrolate—Dysgeusia—Temozolomide—malignant glioma	0.00743	0.0101	CcSEcCtD
Glycopyrrolate—Vision blurred—Carmustine—malignant glioma	0.0074	0.01	CcSEcCtD
Glycopyrrolate—Agitation—Carmustine—malignant glioma	0.00722	0.00977	CcSEcCtD
Glycopyrrolate—Vision blurred—Temozolomide—malignant glioma	0.00715	0.00969	CcSEcCtD
Glycopyrrolate—Agitation—Temozolomide—malignant glioma	0.00698	0.00944	CcSEcCtD
Glycopyrrolate—Convulsion—Carmustine—malignant glioma	0.00681	0.00921	CcSEcCtD
Glycopyrrolate—Hypertension—Carmustine—malignant glioma	0.00678	0.00918	CcSEcCtD
Glycopyrrolate—Palpitations—Temozolomide—malignant glioma	0.00671	0.00908	CcSEcCtD
Glycopyrrolate—Convulsion—Temozolomide—malignant glioma	0.00658	0.0089	CcSEcCtD
Glycopyrrolate—Hypertension—Temozolomide—malignant glioma	0.00655	0.00887	CcSEcCtD
Glycopyrrolate—Confusional state—Carmustine—malignant glioma	0.00646	0.00875	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00642	0.00869	CcSEcCtD
Glycopyrrolate—Oedema—Carmustine—malignant glioma	0.00641	0.00868	CcSEcCtD
Glycopyrrolate—Infection—Carmustine—malignant glioma	0.00637	0.00862	CcSEcCtD
Glycopyrrolate—Dry mouth—Temozolomide—malignant glioma	0.00632	0.00856	CcSEcCtD
Glycopyrrolate—Tachycardia—Carmustine—malignant glioma	0.00626	0.00847	CcSEcCtD
Glycopyrrolate—Confusional state—Temozolomide—malignant glioma	0.00625	0.00846	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Temozolomide—malignant glioma	0.0062	0.00839	CcSEcCtD
Glycopyrrolate—Oedema—Temozolomide—malignant glioma	0.0062	0.00839	CcSEcCtD
Glycopyrrolate—Infection—Temozolomide—malignant glioma	0.00616	0.00833	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Temozolomide—malignant glioma	0.00608	0.00823	CcSEcCtD
Glycopyrrolate—Skin disorder—Temozolomide—malignant glioma	0.00602	0.00815	CcSEcCtD
Glycopyrrolate—Hypotension—Carmustine—malignant glioma	0.00599	0.00811	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Temozolomide—malignant glioma	0.00599	0.00811	CcSEcCtD
Glycopyrrolate—Insomnia—Carmustine—malignant glioma	0.0058	0.00785	CcSEcCtD
Glycopyrrolate—Somnolence—Carmustine—malignant glioma	0.0057	0.00772	CcSEcCtD
Glycopyrrolate—Insomnia—Temozolomide—malignant glioma	0.0056	0.00759	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00554	0.00749	CcSEcCtD
Glycopyrrolate—Somnolence—Temozolomide—malignant glioma	0.00551	0.00746	CcSEcCtD
Glycopyrrolate—Pain—Carmustine—malignant glioma	0.00548	0.00742	CcSEcCtD
Glycopyrrolate—Constipation—Carmustine—malignant glioma	0.00548	0.00742	CcSEcCtD
Glycopyrrolate—Dyspepsia—Temozolomide—malignant glioma	0.00545	0.00738	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00535	0.00724	CcSEcCtD
Glycopyrrolate—Fatigue—Temozolomide—malignant glioma	0.00534	0.00723	CcSEcCtD
Glycopyrrolate—Constipation—Temozolomide—malignant glioma	0.0053	0.00717	CcSEcCtD
Glycopyrrolate—Pain—Temozolomide—malignant glioma	0.0053	0.00717	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Carmustine—malignant glioma	0.00528	0.00715	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Carmustine—malignant glioma	0.00524	0.0071	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Temozolomide—malignant glioma	0.00511	0.00691	CcSEcCtD
Glycopyrrolate—Abdominal pain—Carmustine—malignant glioma	0.00507	0.00686	CcSEcCtD
Glycopyrrolate—Body temperature increased—Carmustine—malignant glioma	0.00507	0.00686	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00507	0.00686	CcSEcCtD
Glycopyrrolate—Urticaria—Temozolomide—malignant glioma	0.00492	0.00666	CcSEcCtD
Glycopyrrolate—Body temperature increased—Temozolomide—malignant glioma	0.0049	0.00663	CcSEcCtD
Glycopyrrolate—Abdominal pain—Temozolomide—malignant glioma	0.0049	0.00663	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Carmustine—malignant glioma	0.00472	0.00639	CcSEcCtD
Glycopyrrolate—Asthenia—Carmustine—malignant glioma	0.0046	0.00623	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Temozolomide—malignant glioma	0.00456	0.00618	CcSEcCtD
Glycopyrrolate—Asthenia—Temozolomide—malignant glioma	0.00445	0.00602	CcSEcCtD
Glycopyrrolate—Pruritus—Temozolomide—malignant glioma	0.00438	0.00593	CcSEcCtD
Glycopyrrolate—Dizziness—Carmustine—malignant glioma	0.00424	0.00574	CcSEcCtD
Glycopyrrolate—Dizziness—Temozolomide—malignant glioma	0.0041	0.00555	CcSEcCtD
Glycopyrrolate—Vomiting—Carmustine—malignant glioma	0.00408	0.00552	CcSEcCtD
Glycopyrrolate—Rash—Carmustine—malignant glioma	0.00404	0.00547	CcSEcCtD
Glycopyrrolate—Dermatitis—Carmustine—malignant glioma	0.00404	0.00547	CcSEcCtD
Glycopyrrolate—Headache—Carmustine—malignant glioma	0.00402	0.00544	CcSEcCtD
Glycopyrrolate—Vomiting—Temozolomide—malignant glioma	0.00394	0.00533	CcSEcCtD
Glycopyrrolate—Rash—Temozolomide—malignant glioma	0.00391	0.00529	CcSEcCtD
Glycopyrrolate—Dermatitis—Temozolomide—malignant glioma	0.0039	0.00528	CcSEcCtD
Glycopyrrolate—Headache—Temozolomide—malignant glioma	0.00388	0.00525	CcSEcCtD
Glycopyrrolate—Nausea—Carmustine—malignant glioma	0.00381	0.00516	CcSEcCtD
Glycopyrrolate—Nausea—Temozolomide—malignant glioma	0.00368	0.00498	CcSEcCtD
Glycopyrrolate—CHRM2—Signaling Pathways—NTRK1—malignant glioma	0.000109	0.000417	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH1—malignant glioma	0.000109	0.000416	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	0.000107	0.000408	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CD80—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FN1—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—F2—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CG—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APC—malignant glioma	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	0.000105	0.000403	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—BAD—malignant glioma	0.000105	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGF—malignant glioma	0.000105	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTPN11—malignant glioma	0.000104	0.000399	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH1—malignant glioma	0.000104	0.000398	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP3—malignant glioma	0.000103	0.000393	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000102	0.000392	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP3—malignant glioma	0.000102	0.000391	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	0.000102	0.00039	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CD80—malignant glioma	0.000102	0.00039	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APC—malignant glioma	0.000102	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CG—malignant glioma	0.000102	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	0.000102	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	0.000101	0.000388	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP3—malignant glioma	0.000101	0.000388	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000101	0.000387	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGF—malignant glioma	0.000101	0.000385	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	0.0001	0.000384	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTPN11—malignant glioma	0.0001	0.000383	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—BRAF—malignant glioma	9.99e-05	0.000382	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTK2—malignant glioma	9.88e-05	0.000378	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTK2—malignant glioma	9.85e-05	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	9.83e-05	0.000376	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	9.8e-05	0.000375	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTK2—malignant glioma	9.75e-05	0.000373	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT2—malignant glioma	9.72e-05	0.000372	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	9.71e-05	0.000371	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HES1—malignant glioma	9.7e-05	0.000371	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—malignant glioma	9.68e-05	0.00037	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HES1—malignant glioma	9.67e-05	0.00037	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NCOR1—malignant glioma	9.65e-05	0.000369	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NCOR1—malignant glioma	9.62e-05	0.000368	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HES1—malignant glioma	9.58e-05	0.000367	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—BRAF—malignant glioma	9.56e-05	0.000366	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NCOR1—malignant glioma	9.52e-05	0.000364	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RAF1—malignant glioma	9.52e-05	0.000364	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RAF1—malignant glioma	9.49e-05	0.000363	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2—malignant glioma	9.4e-05	0.00036	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RAF1—malignant glioma	9.4e-05	0.00036	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—malignant glioma	9.38e-05	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2—malignant glioma	9.37e-05	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CD—malignant glioma	9.34e-05	0.000357	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT2—malignant glioma	9.31e-05	0.000356	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	9.29e-05	0.000356	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2—malignant glioma	9.28e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—malignant glioma	9.27e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	9.26e-05	0.000354	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PIK3CA—malignant glioma	9.25e-05	0.000354	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	9.24e-05	0.000354	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	9.21e-05	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	9.17e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—KRAS—malignant glioma	9.15e-05	0.00035	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	9.12e-05	0.000349	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—malignant glioma	8.97e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	8.95e-05	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGF2—malignant glioma	8.94e-05	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—malignant glioma	8.94e-05	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	8.93e-05	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	8.9e-05	0.000341	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	8.86e-05	0.000339	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—malignant glioma	8.85e-05	0.000339	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	8.82e-05	0.000337	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—KRAS—malignant glioma	8.76e-05	0.000335	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGF2—malignant glioma	8.56e-05	0.000328	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CG—malignant glioma	8.54e-05	0.000327	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—malignant glioma	8.53e-05	0.000327	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—malignant glioma	8.51e-05	0.000326	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TERT—malignant glioma	8.5e-05	0.000325	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TERT—malignant glioma	8.48e-05	0.000324	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—malignant glioma	8.42e-05	0.000322	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	8.4e-05	0.000322	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TERT—malignant glioma	8.39e-05	0.000321	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MDM2—malignant glioma	8.37e-05	0.00032	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAF1—malignant glioma	8.34e-05	0.000319	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFB—malignant glioma	8.3e-05	0.000318	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFB—malignant glioma	8.27e-05	0.000317	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGFR1—malignant glioma	8.26e-05	0.000316	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ERBB2—malignant glioma	8.25e-05	0.000316	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—malignant glioma	8.24e-05	0.000315	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGFR1—malignant glioma	8.23e-05	0.000315	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFB—malignant glioma	8.19e-05	0.000314	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGFR1—malignant glioma	8.15e-05	0.000312	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	8.14e-05	0.000312	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—malignant glioma	8.13e-05	0.000311	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—malignant glioma	8.11e-05	0.00031	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	8.05e-05	0.000308	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—malignant glioma	8.03e-05	0.000307	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MDM2—malignant glioma	8.01e-05	0.000307	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAF1—malignant glioma	7.99e-05	0.000306	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ERBB2—malignant glioma	7.9e-05	0.000302	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—malignant glioma	7.87e-05	0.000301	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—malignant glioma	7.84e-05	0.0003	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—malignant glioma	7.82e-05	0.000299	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	7.8e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—malignant glioma	7.78e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.76e-05	0.000297	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—malignant glioma	7.75e-05	0.000297	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—malignant glioma	7.68e-05	0.000294	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	7.56e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CD—malignant glioma	7.51e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—malignant glioma	7.49e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—malignant glioma	7.49e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—F2—malignant glioma	7.49e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FN1—malignant glioma	7.49e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—malignant glioma	7.48e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FN1—malignant glioma	7.46e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—F2—malignant glioma	7.46e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BAD—malignant glioma	7.4e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FN1—malignant glioma	7.39e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—F2—malignant glioma	7.39e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BAD—malignant glioma	7.37e-05	0.000282	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	7.33e-05	0.00028	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	7.3e-05	0.000279	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BAD—malignant glioma	7.3e-05	0.000279	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	7.24e-05	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	7.23e-05	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CD80—malignant glioma	7.18e-05	0.000275	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—malignant glioma	7.17e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	7.16e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APC—malignant glioma	7.16e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—malignant glioma	7.16e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CD80—malignant glioma	7.15e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	7.14e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APC—malignant glioma	7.14e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CD80—malignant glioma	7.09e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGF—malignant glioma	7.08e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—malignant glioma	7.08e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	7.07e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APC—malignant glioma	7.07e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGF—malignant glioma	7.06e-05	0.00027	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTPN11—malignant glioma	7.04e-05	0.000269	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTEN—malignant glioma	7.04e-05	0.000269	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTPN11—malignant glioma	7.02e-05	0.000268	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGF—malignant glioma	6.99e-05	0.000268	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTPN11—malignant glioma	6.95e-05	0.000266	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—malignant glioma	6.86e-05	0.000263	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—malignant glioma	6.78e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTEN—malignant glioma	6.74e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BRAF—malignant glioma	6.73e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BRAF—malignant glioma	6.71e-05	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.65e-05	0.000254	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—malignant glioma	6.57e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT2—malignant glioma	6.56e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CB—malignant glioma	6.54e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT2—malignant glioma	6.53e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—malignant glioma	6.53e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—malignant glioma	6.51e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—malignant glioma	6.48e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.47e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.44e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—malignant glioma	6.35e-05	0.000243	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	6.3e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—malignant glioma	6.29e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	6.28e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	6.24e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	6.22e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	6.22e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—KRAS—malignant glioma	6.17e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	6.16e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—KRAS—malignant glioma	6.15e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—KRAS—malignant glioma	6.09e-05	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—malignant glioma	6.09e-05	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGF2—malignant glioma	6.03e-05	0.000231	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—malignant glioma	6.03e-05	0.000231	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGF2—malignant glioma	6.01e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.95e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—malignant glioma	5.85e-05	0.000224	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—malignant glioma	5.72e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	5.67e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTEN—malignant glioma	5.66e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	5.65e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MDM2—malignant glioma	5.64e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MDM2—malignant glioma	5.62e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAF1—malignant glioma	5.62e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAF1—malignant glioma	5.61e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—malignant glioma	5.6e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.59e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.57e-05	0.000213	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB2—malignant glioma	5.56e-05	0.000213	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.55e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB2—malignant glioma	5.55e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.49e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	5.49e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—malignant glioma	5.48e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	5.47e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.42e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KRAS—malignant glioma	5.4e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—malignant glioma	5.28e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—malignant glioma	5.26e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—malignant glioma	5.21e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KRAS—malignant glioma	5.17e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	5.1e-05	0.000195	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	5.08e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—malignant glioma	5.05e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—malignant glioma	5.04e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—malignant glioma	5.03e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	5.03e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—malignant glioma	5.03e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.98e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—malignant glioma	4.98e-05	0.00019	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	4.96e-05	0.00019	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—malignant glioma	4.8e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—malignant glioma	4.77e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—malignant glioma	4.76e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	4.75e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTEN—malignant glioma	4.74e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTEN—malignant glioma	4.73e-05	0.000181	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.71e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.68e-05	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—malignant glioma	4.63e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—malignant glioma	4.61e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—malignant glioma	4.6e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.57e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—malignant glioma	4.28e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—malignant glioma	4.27e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—malignant glioma	4.24e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—malignant glioma	4.23e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—malignant glioma	4.23e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—malignant glioma	4.19e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—malignant glioma	4.05e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—malignant glioma	3.99e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—malignant glioma	3.94e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—malignant glioma	3.93e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—malignant glioma	3.89e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—malignant glioma	3.88e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—malignant glioma	3.86e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—malignant glioma	3.84e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.81e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KRAS—malignant glioma	3.64e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KRAS—malignant glioma	3.63e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.6e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	3.35e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	3.34e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.3e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—malignant glioma	3.26e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—malignant glioma	3.24e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—malignant glioma	3.23e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—malignant glioma	3.2e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.73e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.73e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.7e-05	0.000103	CbGpPWpGaD
